Third, the profiling of the CD34+CD38− BM compartment with a 97-plex antibody panel to provide higher resolution of immature HSPCs (see below and Extended Data Fig. 9c,d) and fourth, a cohort of 12 AML patients (see below and Fig. 4). This evidence concerns the gene CD34 and acute myeloid leukemia.